These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24389307)

  • 1. Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis.
    Kazgan N; Metukuri MR; Purushotham A; Lu J; Rao A; Lee S; Pratt-Hyatt M; Lickteig A; Csanaky IL; Zhao Y; Dawson PA; Li X
    Gastroenterology; 2014 Apr; 146(4):1006-16. PubMed ID: 24389307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.
    Purushotham A; Xu Q; Lu J; Foley JF; Yan X; Kim DH; Kemper JK; Li X
    Mol Cell Biol; 2012 Apr; 32(7):1226-36. PubMed ID: 22290433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.
    Wellman AS; Metukuri MR; Kazgan N; Xu X; Xu Q; Ren NSX; Czopik A; Shanahan MT; Kang A; Chen W; Azcarate-Peril MA; Gulati AS; Fargo DC; Guarente L; Li X
    Gastroenterology; 2017 Sep; 153(3):772-786. PubMed ID: 28552621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCo(H2)ding the metabolic functions of SIRT1 in the intestine.
    Lefebvre P; Staels B
    Gastroenterology; 2014 Apr; 146(4):893-6. PubMed ID: 24566103
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.
    Miyata M; Matsuda Y; Nomoto M; Takamatsu Y; Sato N; Hamatsu M; Dawson PA; Gonzalez FJ; Yamazoe Y
    Drug Metab Dispos; 2009 Feb; 37(2):338-44. PubMed ID: 18988759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.
    Thomas C; Landrier JF; Gaillard D; Grober J; Monnot MC; Athias A; Besnard P
    Gut; 2006 Sep; 55(9):1321-31. PubMed ID: 16484503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
    Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
    Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
    Dawson PA
    Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
    Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
    J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4.
    Out C; Patankar JV; Doktorova M; Boesjes M; Bos T; de Boer S; Havinga R; Wolters H; Boverhof R; van Dijk TH; Smoczek A; Bleich A; Sachdev V; Kratky D; Kuipers F; Verkade HJ; Groen AK
    J Hepatol; 2015 Sep; 63(3):697-704. PubMed ID: 26022694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Dyslipidemia in Obesity-Unique Regulation of Ileal Villus Cell Brush Border Membrane Sodium-Bile Acid Cotransport.
    Sundaram S; Palaniappan B; Nepal N; Chaffins S; Sundaram U; Arthur S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31623375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of altered bile acid homeostasis in organic solute transporter-alpha knockout mice.
    Lan T; Haywood J; Rao A; Dawson PA
    Dig Dis; 2011; 29(1):18-22. PubMed ID: 21691100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
    García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
    Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.